These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 12487927)
21. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332 [TBL] [Abstract][Full Text] [Related]
22. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study. Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436 [TBL] [Abstract][Full Text] [Related]
23. Survivin expression in ovarian cancer. Liguang Z; Peishu L; Hongluan M; Hong J; Rong W; Wachtel MS; Frezza EE Exp Oncol; 2007 Jun; 29(2):121-5. PubMed ID: 17704744 [TBL] [Abstract][Full Text] [Related]
24. [Relationship of cyclooxygenase 2 expression and chemotherapy response and prognosis in human ovarian carcinoma]. Lou WZ; Shen K; Zhang Y; Lang JH Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):529-32. PubMed ID: 15363351 [TBL] [Abstract][Full Text] [Related]
25. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]. Zhan J; Tang XD Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218 [TBL] [Abstract][Full Text] [Related]
26. [Expression of DNA methyltransferase 1, 3A and 3B mRNA in the epithelial ovarian carcinoma]. Chen CL; Yan X; Gao YN; Liao QP Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):770-4. PubMed ID: 16324253 [TBL] [Abstract][Full Text] [Related]
27. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280 [TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256 [TBL] [Abstract][Full Text] [Related]
29. Modulation of the expression and activity of cyclooxygenases in normal and accelerated erythropoiesis. Rocca B; Secchiero P; Celeghini C; Ranelletti FO; Ciabattoni G; Maggiano N; Habib A; Ricerca BM; Barbarotto E; Patrono C; Zauli G Exp Hematol; 2004 Oct; 32(10):925-34. PubMed ID: 15504548 [TBL] [Abstract][Full Text] [Related]
30. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma. Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188 [TBL] [Abstract][Full Text] [Related]
31. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis. Minter HA; Eveson JW; Huntley S; Elder DJ; Hague A Clin Cancer Res; 2003 May; 9(5):1885-97. PubMed ID: 12738747 [TBL] [Abstract][Full Text] [Related]
32. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma. Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D J BUON; 2007; 12(1):99-104. PubMed ID: 17436409 [TBL] [Abstract][Full Text] [Related]
33. Prostaglandin E(2) and 6-keto-prostaglandin F(1alpha) production is elevated following traumatic injury to sciatic nerve. Muja N; DeVries GH Glia; 2004 Apr; 46(2):116-29. PubMed ID: 15042580 [TBL] [Abstract][Full Text] [Related]
34. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106 [TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2. Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191 [TBL] [Abstract][Full Text] [Related]
37. Alterations in plasma and tissue prostaglandin levels in rabbits during luteal regression. Miller JB; Jarosik C; Stanisic D; Wilson L Biol Reprod; 1983 Nov; 29(4):824-32. PubMed ID: 6688954 [TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Urick ME; Johnson PA Gynecol Oncol; 2006 Nov; 103(2):673-8. PubMed ID: 16797680 [TBL] [Abstract][Full Text] [Related]
39. [Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors]. Cai Y; Shao SL; Wang QH; Yan LJ; Wang XY; Wang LX Ai Zheng; 2007 Nov; 26(11):1188-93. PubMed ID: 17991316 [TBL] [Abstract][Full Text] [Related]
40. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Seo SS; Song YS; Kang DH; Park IA; Bang YJ; Kang SB; Lee HP Gynecol Oncol; 2004 Mar; 92(3):927-35. PubMed ID: 14984962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]